State-of-the-art MALDI imaging and MALDI-based assay technology is enabling scientists at Mannheim Technical University to break new ground in drug research.
Working with Bruker
The Center for Mass Spectrometry and Optical Spectroscopy (CeMOS) at Mannheim Technical University of Applied Sciences, co-founded by Prof. Dr. Carsten Hopf, uses the most sophisticated mass spectrometry (MS) technology for applications in (bio)pharmaceutical drug discovery and production.
"From MS imaging to MALDI MS-based drug discovery, my work follows a path between the two worlds of industry and academia, to solve some of the most complex questions from both sides, using advanced MS technology from Bruker.”
Mannheim Technical University
Dr. Carsten Hopf is Professor of Drug Discovery in the Department of Biotechnology at the Mannheim Technical University, Germany. His background in both academic research and industry places him in a unique position to drive Mannheim Technical University’s goal to unite teaching and research in close alignment with industry needs. Dr. Hopf completed his PhD in biochemistry at the Max Planck Institute for Developmental Biology, Tübingen, before moving to the US to become an EMBO (European Molecular Biology Organization) postdoctoral fellow in the Department of Neuroscience at Johns Hopkins University School of Medicine (Baltimore, MD).Upon returning to Germany, Dr. Hopf joined the then new biotechnology company Cellzome in Heidelberg in 2001, which is now part of GlaxoSmithKline, focusing on proteomics-based drug discovery. While working at Cellzome, he began teaching and researching at Mannheim Technical University in 2005. In 2014, he decided to focus on academia, applying his experience in the biotech and pharma industries to provide new solutions, techniques and applications to pharma.Dr. Hopf’s laboratory at Mannheim Technical University purchased its first MS instrument in 2008, and began its focus on niche, emerging applications in the pharma industry, with the potential to solve many questions in drug dis-covery and production. Using an ever-increasing collection of advanced analytical technology, Dr. Hopf co-founded the Center for Mass Spectrometry and Optical Spectroscopy (CeMOS) at Mannheim Technical University in 2018, bringing together specialists from a range of areas to answer some of the most complex challenges in drug discovery.